Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
56 /100
HIGH RISK
Score updated Oct 13, 2026

NDRA — ENDRA Life Sciences Inc. Dilution Risk Tracker

Track NDRA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track NDRA — Get alerts when the score changes →

As of October 13, 2026, ENDRA Life Sciences Inc. (NDRA) has a DilutionWatch DilutionScore of 56/100, rated HIGH dilution risk. ENDRA Life Sciences Inc. has a market capitalization of $7.70M, 1.50M shares outstanding, 1 institutional holders tracked. Stored dilution-related fields include 31.7K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
85
📊 Float Risk
30
⚠️ Warrant Exposure
15
🔄 Convertible Debt
40

Dilution Forecast

⛅
Watch
Minor dilution signals detected
model est. 22%
💰 Capital Raise model 35%
• Low cash runway: 3 months remaining
🔄 Reverse Split model est. 15%
• Only 3 months cash — financial pressure
🔔 Track NDRA — Get forecast alerts →

Market Data

Market Cap$7.70M
Shares Outstanding1.50M
Float1.20M
Cash$1.74M
DebtN/A
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore56/100DilutionWatch score record
Shares Outstanding1.50MVerified float table or market cache
Public Float1.20MVerified float table or market cache
Market Cap$7.70MMarket data cache
Cash Runway3.0 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants31.7KSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 4 5, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

1 institutional holders · 12.8K shares
#1 Marex Group plc 12.8K shares

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest28.2K
Days to Cover1.0
% of Float2.4%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-10-02
xbrl XBRL CONVERTIBLE 2022-03-30
4 INSIDER TRANSACTION 2026-03-04
4 INSIDER TRANSACTION 2026-03-04
4 INSIDER TRANSACTION 2026-01-23
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual NDRA Dilution Snapshot

ENDRA Life Sciences Inc. (NDRA) has a DilutionScore of 56/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

NDRA's DilutionScore is currently 56/100 (High risk), with 5 score changes tracked over 89 days. The score deteriorated from 60/100 (High risk).

Period Score Risk Level Duration
Oct 02 – Oct 13, 202656/100HIGH12 days
Oct 01, 202660/100HIGH1 day
Aug 22 – Sep 30, 202656/100HIGH40 days
Aug 14 – Aug 21, 202652/100HIGH7 days
Jul 20 – Aug 13, 202648/100MEDIUM25 days
Jul 16 – Jul 19, 202653/100HIGH4 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

NDRA shares outstanding have decreased 17.1% from 1.50M (Apr 2026) to 1.24M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 19, 20261.24M1.20M▲ 2.36%
Apr 11, 20261.24M1.17M▲ 0.39%
Apr 04, 20261.50M1.17M▲ 6.37%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track NDRA Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment NDRA files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking NDRA — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for NDRA
NDRA FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.